验证数据展示
经过测试的应用
| Positive FC detected in | human PBMCs | 
推荐稀释比
| 应用 | 推荐稀释比 | 
|---|---|
| Flow Cytometry (FC) | FC : 0.2 ug per 10^6 cells in 100 μl suspension | 
| This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
产品信息
65254-1-Ig targets CD35 in FC applications and shows reactivity with human samples.
| 经测试应用 | FC Application Description | 
| 经测试反应性 | human | 
| 免疫原 | 
                                             Human CD35 from Acute monocytic leukemia cells and normal blood monocytes 种属同源性预测 | 
                                    
| 宿主/亚型 | Mouse / IgG1, kappa | 
| 抗体类别 | Monoclonal | 
| 产品类型 | Antibody | 
| 全称 | complement component (3b/4b) receptor 1 (Knops blood group) | 
| 别名 | KN, E11, CR1, Complement receptor type 1, C3BR | 
| 计算分子量 | 224 kDa | 
| GenBank蛋白编号 | NM_000573 | 
| 基因名称 | CR1 | 
| Gene ID (NCBI) | 1378 | 
| ENSEMBL Gene ID | ENSG00000203710 | 
| RRID | AB_3084912 | 
| 偶联类型 | Unconjugated | 
| 形式 | Liquid | 
| 纯化方式 | Affinity purification | 
| UNIPROT ID | P17927 | 
| 储存缓冲液 | PBS with 0.09% sodium azide, pH 7.3. | 
| 储存条件 | Store at 2-8°C. Stable for one year after shipment. | 
背景介绍
CD35, also known as complement receptor type 1 (CR1) or C3b/C4b receptor, is a single-chain glycoprotein consisting of 30 repeating homologous protein domains known as short consensus repeats (~60 amino acids each) followed by transmembrane and cytoplasmic domains (PMID: 8765013). CD35 is variably expressed by granulocytes, monocytes, B cells, some T cells, erythrocytes, follicular dendritic cells, Langerhans cells, and glomerular podocytes (PMID: 19004497). CD35 acts as a receptor for C3b and C4b and plays important roles in the regulation of the complement cascade and clearance of immune complexes.
实验方案
| Product Specific Protocols | |
|---|---|
| FC protocol for CD35 antibody 65254-1-Ig | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 

